NCT00814047View on ClinicalTrials.gov

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

PHASE4CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions

Blood Flow VelocityAutoregulationOcular Physiology

Interventions

DRUG

Yohimbine hydrochloride

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER